CMPD

 
Common Stock Alternative Reporting
Pink Current Information
 

OTC Disclosure & News Service

 

CompuMed Appoints Lee Keddie President and CEO

Jan 13, 2016

OTC Disclosure & News Service

- CompuMed Appoints Lee Keddie President and CEO

CompuMed Appoints Lee Keddie President and CEO

PR Newswire

LOS ANGELES, January 13, 2016 /PRNewswire/ --

CompuMed, Inc. (OTCPink: CMPD), a leader in providing Enterprise Telemedicine Solutions, announced today that Lee Keddie is the new President and CEO of the Company. Previously, Lee Keddie and David Pointer were serving together as Co-Interim CEOs. David Pointer will continue in his role as Chairman of the Board. Laura Carroll, who has been extremely helpful in assisting Lee throughout the leadership transition over the past two months, continues as CompuMed's CFO.  

"Lee's background and experience in customer-centric, product and service businesses, as well as his tenure as a CompuMed board member has allowed a seamless transition," commented David Pointer.

"CompuMed has made great strides over these past months in enhancing the technology behind our service offering. We are proud of the great relationships we have developed with our physician partners, the growing breadth of services we can offer to our customers, and the strong team we have at CompuMed," Lee Keddie stated.  

Mr. Keddie brings engineering and executive experience to CompuMed, including expertise in developing scalable systems. He was the President and General Manager of HKX Inc., where company revenues increased by eight times over his fourteen-year tenure. HKX provided hydraulic system kits within the construction equipment market and was sold to Diploma PLC. Mr. Keddie also spent eight years working as an Aerospace Engineer for a number of companies within the aeronautical field, including McDonnell Douglas and Boeing. He received a degree in Mechanical Engineering from the University of Waterloo.

About CompuMed, Inc. 

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at http://www.compumedinc.com.

Forward-Looking Statements  

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

CompuMed, Inc. Investor Relations can be reached at investorrelations@compumedinc.com or (310) 258-5000 x117


SOURCE CompuMed

Copyright © 2016 PR Newswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.